
Overview
Background
Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)
Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.
Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.
Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.
Availability
- Emeritus Professor Sue Tett is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor (Honours), University of Sydney
- Doctor of Philosophy, University of Sydney
Research interests
-
Clinical pharmacokinetics and pharmacodynamics
Many projects being undertaken to define better dosing options to give improved patient outcomes - eg. in people who have received organ transplants (tacrolimus, mycophenolate, sirolimus) or who need other immunosuppressants (eg. leflunomide in people with rheumatoid arthritis).
-
Quality use of Medicines
Numerous projects designed to improve how medicines are used - particular interests in health care teams, including consumers; rural health; medication use and misuse and international comparisons of prescription medication use
Works
Search Professor Sue Tett’s works on UQ eSpace
2010
Book
Quality use of medicines: the appropriateness of medicine naming and labelling; sound-alike, look-alike medicine names
Ostini, R., Roughead, E. E., Kirkpatrick, C. M. J., Monteith, G. and Tett, S. E. (2010). Quality use of medicines: the appropriateness of medicine naming and labelling; sound-alike, look-alike medicine names. Not available: National Medicines Policy Committee.
2010
Journal Article
An intervention to improve benzodiazepine use-a new approach
Smith, Alesha and Tett, Susan E. (2010). An intervention to improve benzodiazepine use-a new approach. Family Practice, 27 (3), 320-327. doi: 10.1093/fampra/cmq007
2010
Journal Article
Towards concordance in healthcare: Perspectives of general practitioners, complementary and alternative medicine practitioners and pharmacists in Australia
Fejzic, J., Emmerton, L. and Tett, S. E. (2010). Towards concordance in healthcare: Perspectives of general practitioners, complementary and alternative medicine practitioners and pharmacists in Australia. Journal of Clinical Pharmacy and Therapeutics, 35 (3), 309-321. doi: 10.1111/j.1365-2710.2009.01093.x
2010
Journal Article
The contribution of injecting drug users in Sydney, Melbourne and Brisbane to rising benzodiazepine use in Australia 2000 to 2006
Smith, A, Tett, S and Hall, W (2010). The contribution of injecting drug users in Sydney, Melbourne and Brisbane to rising benzodiazepine use in Australia 2000 to 2006. Australian And New Zealand Journal of Public Health, 34 (3), 315-319. doi: 10.1111/j.1753-6405.2010.00533.x
2010
Journal Article
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
Staatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II. Clinical Pharmacokinetics, 49 (4), 207-221. doi: 10.2165/11317550-000000000-00000
2010
Conference Publication
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
Kuypers, Dirk R. J., Le Meur, Yannick, Cantarovich, Marcelo, Tredger, Michael J., Tett, Susan E., Cattaneo, Dario, Tönshoff, Burkhard, Holt, David W., Chapman, Jeremy and Van Gelder, Teun (2010). Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. doi: 10.2215/CJN.07111009
2010
Journal Article
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
Kuypers, Dirk R. J., Le Meur, Yannick, Cantarovich, Marcel, Tredger, Michael J., Tett, Susan E., Cattaneo, Dario, Tonshoff, Burkhard, Holt, David W., Chapman, Jeremy, van Gelder, Teun, for The Transplantation Society (TTS) Consensus Group on TDM of MPA and Staatz, Christine E. (2010). Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clinical Journal of the American Society of Nephrology, 5 (2), 341-358. doi: 10.2215/CJN.07111009
2010
Journal Article
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I
Staatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clinical Pharmacokinetics, 49 (3), 141-175. doi: 10.2165/11317350-000000000-00000
2009
Journal Article
The Queensland experience of participation in a national drug use evaluation project - Community-Acquired Pneumonia-Towards Improving Outcomes Nationally (CAPTION)
Pulver, Lisa K., Tett, Susan E. and Coombes, Judith (2009). The Queensland experience of participation in a national drug use evaluation project - Community-Acquired Pneumonia-Towards Improving Outcomes Nationally (CAPTION). BMC Pulmonary Medicine, 9 (1) 38, 1-6. doi: 10.1186/1471-2466-9-38
2009
Journal Article
Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2)inhibitors use in Australia and Nova Scotia (Canada)
Barozzi, Nadia, Sketris, Ingrid, Cooke, Charmaine and Tett, Susan (2009). Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2)inhibitors use in Australia and Nova Scotia (Canada). British Journal of Clinical Pharmacology, 68 (1), 106-115. doi: 10.1111/j.1365-2125.2009.03410.x
2009
Journal Article
A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme
Staatz, Christine E., Smith, Alesha J. and Tett, Susan E. (2009). A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme. Pharmacoepidemiology and drug safety, 18 (5), 386-392. doi: 10.1002/pds.1726
2009
Journal Article
How Do Different Age Groups Use Benzodiazepines and Antidepressants?: Analysis of an Australian Administrative Database, 2003–6
Smith, Alesha and Tett, Sue E. (2009). How Do Different Age Groups Use Benzodiazepines and Antidepressants?: Analysis of an Australian Administrative Database, 2003–6. Drugs & Aging, 26 (2), 113-122. doi: 10.2165/0002512-200926020-00003
2009
Journal Article
Systematic review of interventions to improve prescribing
Ostini, Remo, Hegney, Desley, Jackson, Claire, Williamson, Margaret, Mackson, Judith M., Gurman, Karin, Hall, Wayne and Tett, Susan E. (2009). Systematic review of interventions to improve prescribing. The Annals of Pharmacotherapy, 43 (3), 502-513. doi: 10.1345/aph.1L488
2009
Journal Article
Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market
Barozzi, N. and Tett, S. E. (2009). Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market. Clinical Rheumatology, 28 (5), 509-519. doi: 10.1007/s10067-008-1077-8
2009
Book
Discharge management of acute coronary syndromes project (DMACS) Queensland Arm
Tett, Susan, Coombes, Judith, Pulver, Lisa and Taylor, Donna (2009). Discharge management of acute coronary syndromes project (DMACS) Queensland Arm. St. Lucia, QLD Australia: The University of Queensland.
2009
Conference Publication
Community pharmacy dispensing of prescription medicine sample packs: Changing the business of medicine initiation?
Kyle, Greg, Nissen, L. M. and Tett, S. E. (2009). Community pharmacy dispensing of prescription medicine sample packs: Changing the business of medicine initiation?. ISPOR 12th Annual European Congress, Paris, France, 24-27 October 2009. Malden, MA, U.S.A.: Blackwell Science. doi: 10.1016/S1098-3015(10)74694-5
2009
Conference Publication
The acute postoperative pain (APOP) project: An Australian quality improvement initiative
McIntosh, K. A., Wai, A., Mackson, J. M., Robertson, M. B., Maxwell, D. J., Kaye, K. I., Pulver, L. K., Taylor, D., Tett, S. E., Tompson, A., Peterson, G. M., Reeves, A., Loh, S. F. and Weekes, L. (2009). The acute postoperative pain (APOP) project: An Australian quality improvement initiative. 26th International Conference: The International Society for Quality in Health Care. Dublin 2009: Designing for Quality, Dublin, Ireland, 11-14 October 2009.
2008
Journal Article
Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2008). Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines. Journal of Clinical Pharmacy and Therapeutics, 33 (5), 553-559. doi: 10.1111/j.1365-2710.2008.00948.x
2008
Journal Article
Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia
Barozzi, Nardia and Tett, Susan E. (2008). Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia. BMC Health Services Research, 8 (Article Number: 196) 196, 196-1-196-9. doi: 10.1186/1472-6963-8-196
2008
Journal Article
A comparison of antidepressant use in Nova Scotia, Canada and Australia
Smith, Alesha J., Sketris, Ingrid, Cook, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiology and Drug Safety, 17 (7), 697-706. doi: 10.1002/pds.1541
Funding
Past funding
Supervision
Availability
- Emeritus Professor Sue Tett is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Towards optimal dosing of new immunosuppressant drugs in solid organ transplants
Improving dosing of immunosuppressant medications in people who have received solid organ transplants. Studies with tacrolimus, mycophenolate or sirolimus can be offered
-
International comparisons of medicines use, investigating pharmaceutical policy and other influences on usage
International comparisons of the use of prescription medicines are important to improve the quality use of medicines across different jurisdictions. Lessons learned from one area can be translated into interventions to be applied to improve medicine use across a number of different health care systems
-
Factors affecting prescribing and use of medicines, including the influence of various marketing strategies (eg. free prescription medicine samples), the influence of location (eg. rural, remote) and
Many factors are know to affect prescribing and use of medicines. Projects in this area will be designed to investigate specific aspects of these factors eg. effects of remote location, influence of free sample medications etc etc
-
Drug usage evaluation across different jurisdictions
Drug usage evaluation, including the feedback, intervention and re-evaluation stages can influence how medicines are prescribed and used. Multicentre studies can have wide ranging influence, and studies across several jurisdictions (eg. hospital/community; public/private) can influence quality use of medicines in sustainable ways across large geographical areas. Projects are offered in the areas, particularly focussing on multi-disciplinary teams and multi-jurisdictional influences
-
Population Pharmacokinetics and Pharmacodynamics of the Newer Immunosuppressant Drug
Supervision history
Completed supervision
-
2009
Doctor Philosophy
Geographical differences, national and international, in the utilization of the benzodiazepine and antidepressant groups of medicines
Principal Advisor
Other advisors: Emeritus Professor Wayne Hall
-
2007
Doctor Philosophy
CONVENTIONAL MEDICINE AND COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) - CONCORDANCE AND PERSPECTIVES OF CONSUMERS, HEALTH PROFESSIONALS AND CAM PRACTITIONERS
Principal Advisor
-
2005
Doctor Philosophy
Use of leflunomide in rheumatoid arthritis
Principal Advisor
-
2004
Doctor Philosophy
Pharmacokinetic studies with sirolimus and tacrolimus
Principal Advisor
-
2002
Doctor Philosophy
POPULATION PHARMACOKINETICS AND PHARMOCODYNAMICS OF THE NEW IMMUNOSUPRESSANT DRUGS
Principal Advisor
-
2002
Doctor Philosophy
QUALITY USE OF MEDICINES: FROM DUE TO RURAL COMMUNITY PHARMACY PRACTICE
Principal Advisor
Other advisors: Emeritus Professor Maree Smith
-
2021
Doctor Philosophy
Evaluating Prediction Methods for Estimating Tacrolimus, Mycophenolate and Prednisolone Exposure Following Adult Kidney Transplantation
Associate Advisor
Other advisors: Dr Christine Staatz
-
2016
Doctor Philosophy
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
Associate Advisor
Other advisors: Dr Christine Staatz
-
2009
Doctor Philosophy
Prescription medicine samples and therapy initiation. Developing a best practice system with community pharmacists in Australia
Associate Advisor
Other advisors: Professor Lisa Nissen
-
2007
Doctor Philosophy
Optimising the assesssment of renal function and determining the renal elimination of drugs using various methodologies
Associate Advisor
Media
Enquiries
Contact Emeritus Professor Sue Tett directly for media enquiries about:
- Clinical pharmacokinetics
- Clinical pharmacy
- Medicine - quality use of
- Pharmacokinetics
- Pharmacy - clinical
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: